Curriculum Vitae Yolande Appelman Personalia

Curriculum Vitae Yolande Appelman
Personalia
Name:
J.E.A. Appelman (Yolande)
Education:
1982
Degree Atheneum ß
1983
State exams physics Atheneum ß
1984
Bachelor Medicine University of Amsterdam
1989
Master Medicine University of Amsterdam
1991
Physician at University of Amsterdam (30-10-1991)
1996
Doctor Degree University of Amsterdam, promoter Prof.dr. K.I. Lie (21-03-1996)
1996
Preliminary training Internal Medicine Academic Medical Center Amsterdam
1997
Trainee Cardiology Academic Medical Center Amsterdam (trainer Prof.dr. K.I. Lie)
2001
Cardiologist University of Amsterdam (AMC, 01-10-2001)
2002
Trainee Interventional Cardiologist St. Antonius, Nieuwegein
2003
Chef de Clinique / Interventional cardiologist St. Antonius, Nieuwegein
2006
Interventional Cardiologist VU University Medical Center, Amsterdam
2007
Clinical manager of the department of clinical cardiology and invasive cardiology VU
University Medical Center
2009
Head Department Invasive Cardiology VU University Medical Center, Amsterdam
2012-
Interventional Cardiologist with research focus on myocardial infarction; gender differences
in coronary artery disease
Supervisor of 4 PhD students
Grants
2012
- Grant 80.000 euro Dutch Heart Foundation for research ACS and gender differences.
2013
- Participation in Dutch Heart Foundation proposal on Gender and cardiovascular disease.
Memberships
2002
Fellow of the Dutch Society of Cardiology (NVVC)
2004
Fellow of the Working group of Interventional Cardiology (WIC) (NVVC)
2009
Fellow of the European Society of Cardiology (ESC)
2011
Member of Women in Innovations (WIN part of the SCAI group, USA)
2012
Member of the Working Group of Acute Coronary Syndrome (ACS) (NVVC)
2013
Invited member of the European Association of Percutaneous Coronary Intervention Women
Committee (EAPCI)
Presentations
2002
PRISON study: presentation, Aspen, USA
2004
Total coronary occlusions: an update, Aspen, USA
2005
Post-graduate course heart failure
2007
- "MRI guided vascular interventions". Interventional Cardiology 2007, 22nd Annual
Interventional Symposium, Aspen, USA. (march)
- "FFR-measurements: an update". Cardiology Symposium, Hospital of Yentai,
Yentai, China. (Apr.)
- Pre-hospital triage in Acute Coronary Syndromes: "The Amsterdam Experience".
The Second Amsterdam Symposium on Acute Coronary Syndromes, NL. (Nov.)
2008
- Pre-hospital triage in ACS: Aspen, USA (Febr.)
- Imaging in Cardiology: lecture for General Practioners NL (June)
- The acute coronary syndrome: lecture for General Practioners NL (June)
- Treatment of HOCM in the cathlab: lecture for cardiovascular Dutch nurses NL (Nov.)
- Angina Pectoris: lecture for General Practioners, NL (Dec.)
2009
- Percutaneous treatment of HOCM. Congress North Netherlands Days Curaçao.
th
(Jan. 22-24 )
- History of stent implantation: has the problem been solved? Amsterdam, The Netherlands
Society of Cardiology, NL. Jubilee congress. (Apr.)
th
- Women with heart disease. Congress NVHVV NHE Acute Cardiac Care. (Sept. 10 )
2010
- New Developments in Interventional Cardiology, Curacao, Netherland Heart Days
(Jan)
- Gender differences in the acute coronary syndrome, Utrecht, CVOI (Febr.)
- Optimal care for Acute Coronary Syndromes, VMS safety program, Utrecht (Apr.)
th
- Venus in the cathlab. Heart for Women congress NVVC, Egmond aan Zee (Nov. 4 ).
2011
- Interventional treatment of hypertension. Curacao, Netherland Heart Days
(Jan, 27-29)
- The effect of EXenatide in the treatment of an Acute Myocardial Infarction: the EXAMI trial.
Interventional Cardiology 26th annual intern. symposium Aspen, Col.USA. (March,13-18).
- Bifurcation stenting: latest developments. CVOI symposium:New developments in
th
interventional cardiology Utrecht Nov 18 .
2012
- Gender differences: a journey through the heart (een hart(s)tocht). Congress: “Men come
from Mars and women from Venus”. Mint Hotel Amsterdam. (Febr. 3-4).
- Results of the EXAMI Trial: Exenatide in Acute Myocardial Infarction. 27th annual
international symposium Interventional Cardiology, 2012 Snowmass, CA, USA.
th
March 8
st
- Women with ACS: Eliminating the Gender Gap. Stent for Life forum Prague. March 1 -2
nd
- “It’s different for girls”. Symposium: Cardiovascular disease in focus 2012. Utrecht. October
2
nd
- Women and ACS: very important! Symposium: Cardiovascular disease: gender differences
th
in your daily practice! Amsterdam October 16 .
- Gender differences in interventional cardiology. Annual CarVasZ symposium with 2012
th
theme cardiovascular male/female differences. Ede. November 30 .
2013
- It’s different for girls. Teaching Master students regarding gender differences in
Cardiovascular disease
th
- Sudden Cardiac Death in Women; Interventional Cardiology 2013; 28 International
th
th
Symposium Snow Mass March 24 -29
- Gender differences in Coronary Artery disease; Interventional Cardiology 2013;
th
th
th
28 International Symposium Snow Mass March 24 -29
-
Women and Cardiovascular disease in daily practice for the general practitioner.
Educational meeting for the general practitioner. Amsterdam November 12
-
th
Dutch Society of Vascular Medicine (NVVG) yearly meeting: Cardiovasclular disease in
th
women. Noordwijk November 29 .
2014
th
- Gender differences in Coronary Artery Disease; Interventional Cardiology, 29 International
Symposium, Snowmass March 9-14, 2014
- “ the day’s after…”, Guidelines for management of (acute) coronary syndromes.
EuroPRevent Amsterdam May 8-10, 2014 Cardiovascular Risk Management, Secondary
Prevention
Organizer of meetings
2007
-International workshop Fractional Flow Reserve for intervention cardiologists, VU University
Medical Center, Amsterdam.
2008
-International workshop Fractional Flow Reserve for intervention cardiologists, VU
University Medical Center, Amsterdam.
-International workshop Fractional Flow Reserve for intervention cardiologists, VU University
Medical Center, Amsterdam.
2009
- Fractional Flow Reserve preceptorship VU University Medical Center, Amsterdam.
th
(March 27 ).
2010
- CVOI course on Gender specific issues in heart and vascular disease (Febr.)
- Optimal care for Acute Coronary Syndromes, VMS safety program, Utrecht, The
th
Netherlands (April 22 )
-Symposium Interventional Cardiology and the future, VU University Medical Center
th
Amsterdam (Sept. 24 ) Symposium was related to the opening festivities of the new
cardiac interventional catheterization laboratory.
2011
- Interventional treatment of hypertension. Curacao, Netherland Heart Days (Jan)
th
- Organizer Dress Red Day September 24 for medical professionals in close
collaboration with the Dutch Heart Foundation
- Creator of website www.kenhethart.nl: regarding everything there is to know with respect to
gender&cardiovascular disease for cardiologists/general practioners and their assistants
2012
- Symposium: “Men are from Mars and women from Venus” supported by MSD. Amsterdam
(febr 3
rd
th
and 4 )
th
- Dress Red Day September 28 for medical professionals in close
collaboration with Dutch Heart Foundation and working group on Gender NVVC
- Meeting for general practitioner. Cardiovascular disease: gender differences
th
in your daily practice! Amsterdam October 16 .
2013
- Women and Career in Cardiology, meeting for women in cardiology during European
Society of Cardiology (ESC) Amsterdam, September 2
nd
with invited speakers: prof
R. Mehran (USA) and prof R. Virmani (USA)
th
- Dress Red Day September 27 for medical professionals and patients in close
collaboration with Dutch Heart Foundation and working group on Gender NVVC
-
Meeting for the general practioner. Cardiovascular disease: gender differences in your
th
daily practice! Amsterdam November 12 .
2014
th
- Workshop: “ Gender disparities in cardiovascular disease” during the 48 annual scientific
rd
meeting of the European Society of Clinical Investigation (ESCI) Utrecht May 1-3 , 2014
Additional positions
2009
- Chairman of the Working group Gender Dutch Society of Cardiology
- Spokesman Netherlands Heart Foundation: 6 minute campaign
- Member Critical Event Committee Side guard study (international)
2010
- Participation in the expert team of VMS Dutch Safety Program regarding ACS.
- Ambassador Netherlands Heart Foundation: campaign Female and heart disease
- Member Critical Event Committee Stentys study (international)
- Investigator in the “BIOMarker study to identify the Acute Risk of a Coronary Syndrome’’.
Study by Erasmus University Rotterdam.
- Member Innovative Medical Devices Initiative Netherlands (IMDI) Theme Committee
ZonMw
- Chairman of the Working group Gender Dutch Society of Cardiology
2012-
- DSMB member Apposition IV trial: randomized, multicenter, safety and effectiveness study
with a selfexpandable stent (international). Genae Associates, Antwerpen.
- Chairman of the Working group Gender Dutch Society of Cardiology until April 2014
- Member IMDI Programme Committee Netherlands ZonMw.
- Member of the Editorial Board Netherlands Heart Journal
- Chairman IMDI Talentprize committee 2011-2012 ZonMw
2014
- Member Advisory board Queen of Hearts Research Program The Queen of Hearts
consortium consists of top researchers from five large academic medical centers in the
Netherlands who have united to improve diagnosis of cardiovascular disease in women with
the focus on diastolic heartfailure. The workflow consists of Biomarkers, Pathogenesis and
Clinical studies;The program is funded by the Dutch Heart Foundation
Primary Investigator
2011
EXAMI study: safety and feasibility study in patients with acute myocardial infarction and
treatment with Exenatide
2012 -
EXAMI II study: efficacy study in patients with acute myocardial infarction and treatment with
Exenatide (starting end of 2012- closing May 2014) Multicenter randomized clinical trial
2013
Patents
PI in VU University Medical Center of HEART-IMPACT study and female specific riskfactors
2010
Image guided plaque ablation: USP 945593
Publications
1.
Appelman YE, Piek JJ, Verhoofstad GG, Gijsbers GH, Van Gemert MJ. Tissue ablation and
gas formation of two excimer laser systems: an in vitro evaluation on porcine aorta. Lasers
Surg Med. 1996;18(2):197-205.
2.
Appelman YE, Piek JJ, Strikwerda S, Tijssen JG, de Feyter PJ, David GK, Serruys PW,
Margolis JR, Koelemay MJ, Montauban van Swijndregt EW, Koolen JJ. Randomised trial of
excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary
artery disease. Lancet. 1996 Jan 13;347(8994):79-84.
3.
Appelman YE, Koolen JJ, Piek JJ, Redekop WK, de Feyter PJ, Strikwerda S, David GK,
Serruys PW, Tijssen JG, van Swijnregt E, Lie KI. Excimer laser angioplasty versus balloon
angioplasty in functional and total coronary occlusions. Am J Cardiol. 1996 Oct 1;78(7):75762.
4.
Appelman YE, Piek JJ, Redekop WK, de Feyter PJ, Koolen JJ, David GK, Strikwerda S, Tijssen JG,
Serruys PW, van Swijndregt E, van Gemert MJ, Lie KI. Clinical events following excimer laser
angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial.
Heart. 1998 Jan;79(1):34-8.
5.
Chamuleau SA, Piek JJ, Hanekamp WB, Appelman YE, Koch KT, Peters RJ, Kok WE, Bloemhard
G, la Rivière GA, David GK. An analogue laser optical disc in comparison with cinefilm for visual
analysis of coronary narrowings before and after coronary angioplasty. Int J Card Imaging. 1998
Feb;14(1):19-26.
6.
Piek JJ, Appelman YE. Excimer Laser Coronary Angioplasty: Lessons From the Randomized Trials.
Curr Interv Cardiol Rep. 1999 Jul;1(2):165-171.
7.
Appelman YE, Piek JJ, van der Wall EE, Redekop WK, van Royen EA, Fioretti PM, de Feyter PJ,
Koolen JJ, Strikwerda S, Serruys PW, David GK, Tijssen JG, Lie KI. Evaluation of the long-term
functional outcome assessed by myocardial perfusion scintigraphy following excimer laser
angioplasty compared to balloon angioplasty in longer coronary lesions. Int J Card Imaging. 2000
Aug;16(4):267-77.
8.
Appelman YE, Doevendans PA. Proteasome inhibition and stress compromise the heart in
chemotherapy. Cardiovasc Res. 2008 Sep 1;79(4):547-8.
9.
Fang YM, Grootenhuijs-Triyasut G, Doevendans PA, Appelman YE. Current status of assessment
of fractional flow reserve. Chin Med J (Engl). 2009 Mar 20;122(6):725-31.
10.
Camenzind E, Wijns W, et al. PROTECT Steering Committee and Investigators. Rationale and
design of het Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT):
randomized controlled trial comparing the incidence of stent thrombosis and clinical events after
sirolimus or zotarolimus drug-eluting stent implantation. Am Heart J. 2009 158(6):902-909.e5.doi:
10.1016/j.ahj.2009/10.002
11.
Slijkhuis W, Mali W, Appelman YE. A historical perspective towards a non-invasive treatment for
patients with atherosclerosis. Neth Heart J. 2009 Apr;17(4):140-4.
12.
Knaapen P, de Haan S, Hoekstra OS, Halbmeijer R, Appelman YE, Groothuis JG, Comans EF,
Meijerink MR, Lammertsma AA, Lubberink M, Götte MJ, van Rossum AC. Cardiac PET-CT:
advanced hybrid imaging for the detection of coronary artery disease. Neth Heart J. 2010
Feb;18(2):90-8.
13.
Oud N., Marques K.M., Bronzwaer J.G.F., Brinckman S., Allaart C.P., de Cock C.C., Appelman YE
Patients with coronary stenosis and a fractional flow reserve of
≥0.75 measured in daily practice at
the VU University Medical Center. Accepted for publication Neth Heart J 2010 Sep;18(9):402-7
14.
Maas A.H., Appelman YE. Gender differences in coronary heart disease. Neth Heart J 2010;18:598602.
15.
Adams R, Appelman YE, Bronzwaer JG, Slagboom T, Amoroso G, van Exter P, Tijssen GP, de
Winter RJ. Implementation of a prehospital triage system for patients with chest pain and logistics for
primary percutaneous coronary intervention in the region of Amsterdam, the Netherlands. Am J
Cardiol 2010 Oct 1;106(7):931-5.
16.
Heijne M, Raijmakers PG, Harms HJ, Lubberink M, Halbmeijer R, Appelman YE, Knaapen P.
Coronary steal: revealing the diagnosis with quantitative cardiac PET/CT. J Nucl Cardiol 2010
Dec;17(6):1118-21.
17.
Feyen D, Sluijter J, Appelman YE, Doevendans PA. Cardiac Stem Cell Transplantation: Exogenous
or Endogenous Repair? CML Cardiology. CML – Cardiology 2010;29(3):61–8.
18.
Slikkerveer J, Veen G, Appelman YE, van Royen N, Kamp O. Therapeutic application of ultrasound:
contrast-enhanced thrombolysis in acute ST-elevation myocardial infarction; the Sonolysis study.
Neth. Heart J 2011 Apr;19(4):200-205.
19.
Urban P, Abizaid A, Banning A et all; e-SELECT Investigators. Stent trombosis and bleeding
complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide
population: a report form the e-SELECT registry. J Am Coll Cardiol. 2011 Mar29;57(13)1445-54
20.
Maas AH, van der Schouw YT, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, Ten
Cate H, Nilsson PM, Huisman MV, Stam HC, Eizema K, Stramba-Badiale M. Red alert for women's
heart: the urgent need for more research and knowledge on cardiovascular disease in women:
Proceedings of the Workshop held in Brussels on Gender Differences in Cardiovascular disease, 29
September 2010. Eur Heart J. 2011 Jun;32(11):1362-8. Epub 2011 Mar 15.
21.
Appelman YE, de Winter RJ. Female platelets are hard to control. Neth. Hearth J 2011 19:449-450.
22.
Groothuis JG, Appelman YE, Meijerink MR, van Rossum AC. Coronary anomaly diagnosed by
computed tomography coronary angiography in a patient with atypical chest pain. Neth. Heart J 2011
Feb;19(2):93-4.
23.
Scholte M, Timmers L, Bernink FJ, Denham RN, Beek AM, Kamp O, Diamant M, Horrevoets AJ,
Niessen HW, Chen WJ, van Rossum AC, van Royen N, Doevendans PA, Appelman YE. Effect of
additional treatment with EXenatide in patients with an acute myocardial infarction (EXAMI): study
th
protocol for a randomized controlled trial. Trials 2011, 12:240 doi:10.1186/1745-6215-12-240 Nov 8
24.
Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML, van Kuijk C,
Allaart CP, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. Coronary
risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a
quantitative [(15)O]H (2)O PET/CT study. Eur J Nucl Med Mol Imaging 2012 Jan;39(1):102-12. Epub
2011 Oct 18.
25.
Slikkerveer J, Kleijn SA, Appelman YE, Porter TR, Veen G, van Rossum AC, Kamp O. Ultrasound
enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation
myocardial infarction: Pilot of the sonolysis study. Ultrasound in Med. & Biol. 2012,38(2):247-252.
26.
Abizaid A, Costa JR, Banning A et al; e-SELECT Investigators. The sirolimus-eluting Cypher Select
coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the eSELECT registry. JACC Cardiovasc Interv.2012 Jan;5(1):64-71
27.
Claassen M, Sybrandy KC, Appelman YE, Asselbergs FW. Gender gap in acute coronary heart
disease: Myth or reality? World J Cardiol 2012 February 26; 4(2): 36-47
28.
Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, Marques KM, van Kuijk C, Allaart
CP, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. Quantitative
relationship between coronary artery calcium score and hyperemic myocardial blood flow as
assessed by hybrid (15)O-water PET/CT imaging in patients evaluated for coronary artery disease. J
Nucl Cardiol. 2012 April;19(2):256-64 Epub 2011 Nov 11
29.
Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman YE, de Kleijn DP. The innate immune
response in reperfused myocardium. Cardiovasc. Res. 2012 May 1;94(2):276-83 Review.
30.
Appelman YE. The Y factor in the cardiac syndrome X. Neth Heart J. 2012 Sep;20(9):345-6
31.
Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Boersma E,
Vranckx P, McFadden E, Serruys PW, O'Neil WW, Jorissen B, Van Leeuwen F, Steg PG; PROTECT
Steering Committee and Investigators. Stent thrombosis and major clinical events at 3 years after
zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, openlabel, controlled trial. Lancet. 2012 Oct 20;380(9851):1396-405. doi: 10.1016/S0140-6736(12)613361. Epub 2012 Aug 27.
32.
Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA,
Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt
TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M, Li YR, Liu K, McDonough CW,
Meijs MF, Middelberg RP, Musunuru K, Nelson CP, O'Connell JR, Padmanabhan S, Pankow JS,
Pankratz N, Rafelt S, Rajagopalan R, Romaine SP, Schork NJ, Shaffer J, Shen H, Smith EN,
Tischfield SE, van der Most PJ, van Vliet-Ostaptchouk JV, Verweij N, Volcik KA, Zhang L, Bailey KR,
Bailey KM, Bauer F, Boer JM, Braund PS, Burt A, Burton PR, Buxbaum SG, Chen W, Cooper-Dehoff
RM, Cupples LA, Dejong JS, Delles C, Duggan D, Fornage M, Furlong CE, Glazer N, Gums JG,
Hastie C, Holmes MV, Illig T, Kirkland SA, Kivimaki M, Klein R, Klein BE, Kooperberg C, KottkeMarchant K, Kumari M, Lacroix AZ, Mallela L, Murugesan G, Ordovas J, Ouwehand WH, Post WS,
Saxena R, Scharnagl H, Schreiner PJ, Shah T, Shields DC, Shimbo D, Srinivasan SR, Stolk RP,
Swerdlow DI, Taylor HA Jr, Topol EJ, Toskala E, van Pelt JL, van Setten J, Yusuf S, Whittaker JC,
Zwinderman AH; LifeLines Cohort Study, Anand SS, Balmforth AJ, Berenson GS, Bezzina CR,
Boehm BO, Boerwinkle E, Casas JP, Caulfield MJ, Clarke R, Connell JM, Cruickshanks KJ,
Davidson KW, Day IN, de Bakker PI, Doevendans PA, Dominiczak AF, Hall AS, Hartman CA,
Hengstenberg C, Hillege HL, Hofker MH, Humphries SE, Jarvik GP, Johnson JA, Kaess BM,
Kathiresan S, Koenig W, Lawlor DA, März W, Melander O, Mitchell BD, Montgomery GW, Munroe
PB, Murray SS, Newhouse SJ, Onland-Moret NC, Poulter N, Psaty B, Redline S, Rich SS, Rotter JI,
Schunkert H, Sever P, Shuldiner AR, Silverstein RL, Stanton A, Thorand B, Trip MD, Tsai MY, van
der Harst P, van der Schoot E, van der Schouw YT, Verschuren WM, Watkins H, Wilde AA,
Wolffenbuttel BH, Whitfield JB, Hovingh GK, Ballantyne CM, Wijmenga C, Reilly MP, Martin NG,
Wilson JG, Rader DJ, Samani NJ, Reiner AP, Hegele RA, Kastelein JJ, Hingorani AD, Talmud PJ,
Hakonarson H, Elbers CC, Keating BJ, Drenos F. Large-Scale Gene-Centric Meta-analysis across
32 Studies Identifies Multiple Lipid Loci. Am J Hum Genet. 2012 Oct 10. pii: S0002-9297(12)004740. doi: 10.1016/j.ajhg.2012.08.032. [Epub ahead of print]
33.
1
Bernink FJP, MD , Timmers L, Diamant M, Scholte M, Beek AM, Kamp O, Marques KMJ, Denham
RD, Chen WJY, Doevendans P, v Rossum, v Royen N, AJG Horrevoets, Appelman YE. Effect of
additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI
study.
Int
J
Cardiol,
epub
2012
Oct
17.
pii:
S0167-5273(12)01325-3.
doi:10.1016/j.ijcard.2012.09.204.
34.
Denham RN, Appelman YE, Verdel GJE. A cataclasm due to spasm. Neth Heart J, epub 2012 Oct
19. DOI 10.1007/s12471-012-0328-0
35.
Vermeersch P, Appelman Y, Horstkotte D, Richardt G, Boland J, Lalmand J, Coussement P,
Castadot M, Janssens L, Agostoni P, Buysschaert I, Suttorp MJ. Safety and efficacy of the cobalt
chromium PRO-Kinetik coronary stent system: results of the MULTIBENE study. Cardiovasc Revasc
Med. 2012 Nov-Dec;13(6):316-20.doi:10.1016/j.carrev.2012.09.006
36.
Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML, Heymans MW,
Tulevski II, van Kuijk C, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen,P.
Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection
of coronary artery disease. J Nucl Med. 2013 Jan;54(1):55-63. doi: 10.2967/jnumed.112.104687.
Epub 2012 Dec 11.
37.
Appelman YE, Lambalk CB. Postmenopausal sex hormones: comparing apples and pears. Neth.
Heart J. 2013 Apr;21(4)1173-4 DOI 10.1007/s12471-013-0385-z
38.
De Waard MC, Biermann H, Brinckman SL, Appelman YE, Driessen RH, Polderman KH, Girbes
AR, Beishuizen A. Automated peritoneal lavage: an extremely rapid and safe way to induce
hypothermia in post-resuscitation patients. Crit Car. 2013 Febr 20;17(1):R31
39.
Ma S, Maeharea A, Hauptmann KE, Guagliumi G, Valsecchi O, Vassileva A, Appelman Y, Sangiorgi
G, Prati F, Mintz GS. Intravascular ultrasound comparison of the self-expandable Sideguart stent in
the side branch vesus a balloon-expandable stent in the main vessel to asses mechanisms of acute
lumen gain in bifurcation lesions. Catheter Cardiovasc Interv 2013 Nov 1;82(5):748-54.
Doi:10.1002/ccd.24953 Epub 2013 June26
40.
Rademaker AEM, Danad I, Groothuis JGJ, Heymans MW, Marcu CB, Knaapen P, Appelman YE.
Comparison of different cardiac risk scores for coronary artery disease in symptomatic women: do
female-specific risk factors matter? European Journal of Preventive Cardiology 2047487313494571,
first published on June 26, 2013 as doi:10.1177/2047487313494571
41.
Verloop WL, Beeftink MM, Nap A, Bots ML, Velthuis BK, Appelman Y, Cramer MJ, Agema WR,
Scholtens AM, Doevendans PA, Allaart CP, Voskuil M. Eur J Heart Fail. 2013 Dec; 15(12):1429-37.
Doi: 10.1093/eurjhf/hft 119.Epub 2013 Jul 24 Renal denervation in heartfailure with normal left
ventricular ejection fraction. Rationale and design of the DIASTOLE (Denervation of the reAl
Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial.
42.
Montalescot G. Bolognese L, et al; ACCOAST Investigators. Pretreatment with prasugrel in nonST-segment elevation acute coronary syndromes. N Engl J Med. 2013 Sep 12;369(11):999-1010.
43.
Bernink FJ, Timmers L, Beek AM, Diamant M, Roos ST, Van Rossum AC, Appelman Y.
Progression in attenuating myocardial reperfusion injury: An overview.
Int J Cardiol. 2014 Jan
1;170(3):261-9.
44.
van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM;
SMART Study Group. The impact of polyvascular disease on long term outcome in percutaneous
coronary intervention patients. Eur J Clin Invest. 2014 Mar;44(3):231-9.
45.
Van der Pouw Kraan TC, Bernink FJ, Yildirim C, Koolwijk P, Baggen JM, Timmers L, Beek AM,
Diamant M, Chen WJ, v Rossum AC, v Royen, Horrevoets AJ, Appelman Y. Systemic Toll-Like
Receptor and Interleukin-18 pathway activation in patients with acute ST elevation myocardial
infarction. J Mol Cell Cardiol. 2014 Feb;67:94-102.
BOOKS
46.
Guideline comparison CVRM and coronary artery disease (Richtlijnen vergelijking cardiovasculair
risicomanagement en coronairlijden). Second edition Editorial board: dr M.J. Wittekoek, dr Y.
Appelman en drs M. Rubens. Bohn Stafleu van Loghum Houten 2013 ISBN 978-90-368-0545-2
47.
The Female Heart: “Desired but under-apreciated”. Manual CVRM in women. (Het vrouwenhart:
“begeerd maar miskend” Leidraad CVRM bij vrouwen). Bohn Staflue van Loghum, Houten 2014
ISBN 978-90-368-0660-2
48.
Queen of Hearts: 22 Dutch female cardiologists discus the most common heart diseases.
(Hartenvrouwen; vrouwelijke cardiologen aan het woord. In hartenvrouwen bespreken 22 vrouwelijke
nederlands hartspecialisten de meest voor- komende hartaandoeningen). Esculaap Media,
Beuningen ISNB 978-94-919-8401-3